Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna® and Cyclofem®) on glucose metabolism and liver function

Contraception

Volumn 57, Issue 2, 1998, Pages 71-81

  D'Arcangues, C ^a   Piaggio, G ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Carbohydrate metabolism; Cyclofem ; Estradiol cypionate; Estradiol valerate; Liver function; Medroxyprogesterone acetate; Mesigyna ; Norethisterone enanthate

Indexed keywords

ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL VALERATE PLUS NORETHISTERONE ENANTATE;

ADULT; ARTICLE; CARBOHYDRATE METABOLISM; CONTRACEPTION; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN RESPONSE; LIVER FUNCTION; MAJOR CLINICAL STUDY;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BLOOD GLUCOSE; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; DRUG COMBINATIONS; ESTRADIOL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE TOLERANCE TEST; HUMANS; INJECTIONS; LIVER; LONGITUDINAL STUDIES; MEDROXYPROGESTERONE 17-ACETATE; NORETHINDRONE;

EID: 0031957457     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00003-1     Document Type: Article

References (35)

1. Facts about once-a-month injectable contraceptives memorandum from a WHO meeting . Bull WHO. 70:1993;677-689.
2. Newton JR, d'Arcangues C, Hall PE. "Once-a-month" combined injectable contraceptives. J Obstet Gynecol. 14:(supp 1):1994;S1-S34.
3. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. Contraception. 56:1997;193-207.
4. Barnham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxydase system. Analyst. 97:(151):1972;142-145.
5. Neese JW, Duncan P, Bayse D, et al. Development and evaluation of a hexokinase/glucose-6-phosphate dehydrogenase procedure for use as a national glucose reference method. HEW Publication No. (CDC) 77-8330, US Dept. of HEW, USPHS, Centers for Disease Control, Atlanta, GA.
6. Hales CN, Randle PI. RIA of insulin with antibody precipitate. Bioch I. 88:1963;137-146.
7. Analytical Section Expert Panel on Enzymes. Approved recommendation on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 4 - IFCC method for gamma-glutamyl transferase. J Clin Chem Clin Biochem. 21:1983;633-646.
8. Recommendations of the German Society for Clinical Chemistry. Standardization of methods for the estimation of enzyme activities in biological fluids. Standard method for determination of alkaline phosphatase (AP) activity. J Clin Chem Clin Biochem. 6:1972;290.
9. Jendrassik L, Grof P. Verfahren zur photometrischen Bestimmung des Bilirubins im Harn. Biochem Z. 296:1938;71-79.
10. Bergmeyer HU, Horder M, Rej J. IFCC Scientific Committee. Analytical Section Expert Panel on Enzymes. Approved recommendation on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2 - IFCC method for aspartate aminotransferase. J Clin Chem Clin Biochem. 24:1986;497-510.
11. Analytical Section Expert Panel on Enzymes. Approved recommendation on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 3 - IFCC method for alanine aminotransferase. Ann Biol Clin. 44:1986;321-334.
12. Reitman S, Frankel JA. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminase. Am J Clin Pathol. 28:1957;56-63.
13. Wynn V, Adams PW, Godsland IF, et al. Comparison of effects of different combined oral contraceptive formulations on carbohydrate and lipid metabolism. Lancet. 1:1979;1045-1049.
14. Ballejo G, Saleem TH, Khan-Dawood FS, et al. The effect of sex steroids on insulin binding by target tissues in the rat. Contraception. 28:1983;413-422.
15. Godsland IF, Crook D, Simpson R, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med. 323:1990;1375-1381.
16. De Pirro R, Forte F, Bertoli A, et al. Changes in insulin receptors during oral contraception. J Clin Endocrinol Metab. 52:1981;29-33.
17. Kalkhoff RK. Metabolic effects of progesterone. Am J Obstet Gynecol. 142:1982;735-738.
18. Orchard TJ, Becker DJ, Kuller LH, et al. Age and sex variations in glucose tolerance and insulin responses parallels with cardiovascular risk . J Chron Dis. 35:1982;123-132.
19. Pyorälä K, Savolainen E, Kaukola S, et al. Plasma insulin as coronary heart disease risk factor relationship to other risk factors and predictive value during 9 1/2 year follow-up of the Helsinki Policemen Study Population . Acta Med Scand. 701:(suppl):1985;38-52.
20. Jarrett RJ. Diabetes and heart disease. 1984;1-23 Elsevier Science, Amsterdam.
21. Reaven GM. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
22. Stout RW. The relationship of abnormal circulating insulin levels to atherosclerosis. Atherosclerosis. 27:1977;1-13.
23. Proudler AJ, Godsland IF, Bruce R, et al. Lipid and carbohydrate metabolic risk markers for coronary heart disease and blood pressure in healthy non-obese premenopausal women of different racial origins in the United Kingdom. Metabolism. 45:1996;328-333.
24. Spellacy WN, Mc Leod AGW, Buhi WC, et al. The effects of medroxyprogesterone acetate on carbohydrate metabolism measurements of glucose, insulin and growth hormone after twelve months' use . Fertil Steril. 23:1972;239-244.
25. Vermeulen A, Thiery M. Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives. Diabetologia. 10:1974;253-259.
26. Tuttle S, Turkington VE. Effects of medroxyprogesterone acetate on carbohydrate metabolism. Obstet Gynecol. 43:1974;685-692.
27. Tankeyoon M, Dusitsin N, Poshyachinda V, et al. A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive. Contraception. 14:1976;199-214.
28. Amatayakul K, Sivassomboon B, Singkamani R. Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women. Contraception. 21:1980;283-297.
29. Amatayakul K, Suriyanon V. The effects of long-acting injectable contraceptives on carbohydrate metabolism. Int J Gynaecol Obstet. 23:1985;361-368.
30. Fahmy K, Abdel-Razik M, Shaaraway M, et al. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile. Contraception. 44:1991;419-430.
31. Chaudhuri C, Bhowmik T, Mukherjea M. Alterations in blood sugar, protein and lipid levels in Indian women by norethisterone enanthate. Int J Fertil. 32:1987;240-244.
32. Griffin M, Heaton DA, McEwan JA. Long-term use of an injectable contraceptive effects of depot-norethisterone oenanthate on carbohydrate metabolism . Contraception. 37:1988;53-60.
33. Adlercreutz H, Tenhunen R. Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med. 49:1970;630-648.
34. Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 333:1995;1118-1127.
35. Saleh FM, Abd-El-Hay MM. Liver function tests after the use of long-acting progestational contraceptives. Contraception. 16:1977;409-416.